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Abstract
In the nervous system, high circuit resolution requires efficient post-signaling clearance of
the neurotransmitter. Glutamate-mediated neurotransmission involves the release of glutamate (Glu)
into the synaptic cleft by the presynaptic cell and binding to glutamate receptors (GluR) on the
postsynaptic cell, leading to activation of a signal transduction cascade. Neurotransmission is
eventually terminated by Glu uptake via glutamate transporters (GluT). Inefficient Glu clearance is
detrimental to precise rapid signaling, can lead to blurring of circuit resolution by inadvertent Glu
spillover to nearby circuits, and may even be neurotoxic. While classical views depict synapses as
insulated by glia, recent technological advances show that synaptic organization in critical brain
regions deviate from this doctrine. Instead, these studies show synapses with far less glial coverage
and a wider extracellular space. How these regions still manage to maintain circuit fidelity is not
clear. Furthermore, Glu clearance is mediated by a number of different GluTs, each with its
specialized sequence, location, and slightly different physiological properties. The significance of
this GluT specialization remains unclear. In this study we propose that robust Glu clearance is
achieved despite poor anatomical insulation through a dynamic interaction between specialized
clearance strategies and specific functional characteristics of GluTs that stem from their differential
sequence/structure. We use transgenics and optogenetics in intact animals to study this relationship in
the transparent nematode C. elegans. We examine sequence differences between different nematode
GluTs and ask if these variations might have functional consequences, by swapping the expression of
one GluT with that of another. We also examine the role of these GluTs in their native locations by
assessing their role in specific synapses. Understanding the differential role of GluTs in diverse
synaptic organizations will promote our comprehension of critical aspects of neurophysiology and
might suggest target sites for the development of therapeutic interventions in Glu-associated
neurodegenerative disorders.

Introduction
Glutamate is the major excitatory neurotransmitter and is found everywhere
Normal communication within the central nervous system (CNS) relies on adequate
neurotransmitter (NT) release by a presynaptic neuron, activation of postsynaptic NT receptors,
and fast removal of NTs, all within well-defined synaptic structures without inadvertent
interruptions to neighboring circuits (Buzsáki, 2010; Hopfield & Tank, 1986; L. C. Katz &
Shatz, 1996). Failure do so, could preclude fast signaling in each synapse or cause spillover NT
to other circuits, thus blurring the resolution of nearby circuits, and can even result in
overstimulation of postsynaptic receptors leading neuronal death (Choi & Rothman, 1990; Malik
& Willnow, 2019). [Figure 1].
In the mammalian CNS, 80-90% of circuits use the same amino acid, L-Glutamate (Glu),
as the predominant NT (Fonnum, 1984). Glu is involved in complex functions during
development and cell migration (Campana et al., 2017; Johnston, 1995; Komuro & Rakic, 1993;
LaMantia, 1995; McDonald et al., 1990; Neves et al., 2008; Rossi & Slater, 1993; Song et al.,
2017; Vallano, 1998). It is central to many processes such as learning and memory (Birur et al.,
2017; Fonnum, 1984; Headley & Grillner, 1990; Neves et al., 2008; Stanley et al., 2017), and
discrimination among different circuit tasks (Rogerson et al., 2014). Upon release of Glu from
the presynaptic neuron into the synaptic cleft, Glu binds to ionotropic (iGluR) and metabotropic
(mGluR) Glu receptors (GluR) (Mayer, 2011; Traynelis et al., 2010). It is extremely important to
regulate the amount of Glu at the synapse because hyperactivity of Glu receptors (GluRs) can
result in neurodegeneration, an event known as excitotoxicity (Choi & Rothman, 1990; Malik &
Willnow, 2019). While the other main excitatory NT, acetylcholine, is rapidly inactivated by
perisynaptic and extrasynaptic acetylcholinesterase, Glu needs to be taken up by a class of high-

affinity secondary-active Glu Transporters (GluTs) (Danbolt, 2001; Jiang & Amara, 2011; Kanai
et al., 2013; Kanner, 2006; Krishnamurthy et al., 2009; Song et al., 2017; Tzingounis &
Wadiche, 2007; Vandenberg & Ryan, 2013; Zhou & Danbolt, 2014). How can synapses retain
circuit specificity when most synapses use the same NT? A commonly held view as a solution is
that synapses are individually insulated thus protected from NT crosstalk.
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Figure 1: Glutamatergic synapse in healthy neurotransmission and in disease: A) Glu signaling in a healthy synapse. Glu
released from presynaptic neuron into the synaptic cleft is taken up by peri synaptic secondary-active neuronal and glial GluTs.
B) a similar synapse in ischemic conditions. Low oxygen levels lead to depleted levels of ATP that is required to maintain the
Na+/K+ gradient by the Na/K ATPase. This in turn leads to inability to uptake Glu by GluT that results in excessive Glu
accumulation at the synapse and over activates GluRs resulting in excitotoxicity.

Critical brain regions lack full synaptic isolation by glia
We must consider the different synapses in different regions of the brain to understand
their unique contributions in maintaining circuit specificity. At Glutamatergic synapses, glial
cells play an important part in maintaining adequate Glu signaling. Some of their roles include:
(1) termination of Glutamatergic neurotransmission via Glu uptake by GluTs (in mammals called

excitatory amino acid transporters or EAATs) (Beart & O’Shea, 2009; Danbolt, 2001;
Vandenberg & Ryan, 2013) and (2) providing full synaptic insulation (Harris, 1999; Huang &
Bergles, 2004; Kandal et al., 1993; Petralia et al., 2016; Vandenberg & Ryan, 2013), as seen in
Purkinje synapses in the cerebellum (Tzingounis & Wadiche, 2007) [Figure 2]. Complete synaptic
insulation is traditionally considered ideal because it provides a physical separation from other
surrounding synapses, preventing crosstalk between the many circuits that use the same NT
(Diamond, 2002; Isaacson, 1999; Mitchell et al., 2007). However, in other critical regions of the
brain, like the in hippocampus, only 1/3 of synapses are associated with glia, so that Glu
spillover might be prominent via the extracellular space (Kullmann & Asztely, 1998; Ventura &
Harris, 1999). How do regions in the brain like the hippocampus maintain high synaptic
resolution is not known. Perhaps synapses are tightly packed together thus limiting the
opportunity for Glu to scape (Marcaggi & Attwell, 2004)?

Figure 2: Hippocampal slice and 3D reconstructions. The blue represents astrocytes, green presynaptic neuron, and
gray post synaptic spine. This image shows few synapses are associated with glia and more glia-poor synapses next
to one another. (From: Ventura & Harris, 1999)

Extracellular space is larger and glial coverage smaller than previously thought
For many years, electron microscopy (EM) was the only tool available that allowed
researcher to have enough subcellular resolution to visualize synapses, including Glu-containing
vesicles and contact with glial cells. Classic EM techniques of acquiring these images involved
chemical fixation, which stabilized the overall synaptic structure and also shrank the tissue. As a
result, synapses appeared tightly packed with a small volume of the extracellular space.
Recently, a fixation method by freezing (cryo-fixed), that is more representative of fresh tissue,
showed the extracellular space (ECS) to be larger and glial coverage volume to be smaller than
previously thought (Hrabetova et al., 2018; Korogod et al., 2015; Tønnesen et al., 2018) [Figure
3]. A larger ECS with less glial coverage suggests there might be an alternative mechanism for

maintaining adequate circuit specificity other than relying on glia. Furthermore, most of the
“added” space were in areas occupied by neurites and synapses (as opposed to cell bodies),
giving further emphasis to the added ECS in areas of chemical NT communication.

Figure 3: Chemical fixation methods showed a decreased representation in the extracellular space. Panels A and B
shows volume differences between chemically-fixed and fresh tissue. Panel C shows ECS (blue color) volume
difference between cryo and chemically fixed tissue. Panel D shows quantification of ECS volume, comparing cryo
and chemically fixed tissue. Panel E shows the percent volume makeup of ECS, glia, and neurites between cryo and
chemically fixed tissue. (From: Korogod et al., (2015).

New idea: Glymphatic System helps to clear debris
Other recent studies, from rodents, have highlighted the presence and importance of a
glymphatic system in the CNS. This idea suggested cerebral spinal fluid (CSF) that filled the
periarterial space, is gently pushed out into the brain parenchyma by the high pressure and
pulsation of the artery. The CSF mixed with interstitial fluid, which helped clear small
macromolecules, is drained into the low-pressured perivenous space (Bakker et al., 2016;
Mesquita et al., 2018; Rasmussen et al., 2018; Tarasoff-Conway et al., 2015) [Figure 4]. Although
a matter of some discussion (Iliff & Simon, 2019), the existence of a possible glymphatic system
in the CNS is gaining recognition (Iliff et al., 2013; Mortensen et al., 2019; Plog et al., 2019).
Furthermore, studies of the extracellular space support the importance of macromolecules
clearance by diffusion and bulk flow in the CNS (Nicholson & Hrabětová, 2017; Syková &
Nicholson, 2008). However, the significance of Glu clearance by diffusion and bulk flow in gliapoor synaptic regions remains understudied. How circuit specificity is achieved in these regions
without anatomical separation or synaptic insulation remains unknown. It is therefore important
to take a closer look at the physiological and molecular components of Glu clearance.

Figure 4: Glymphatic system: CSF exciting from the periarterial space mixes with ECS in the brain parenchyma
and finally drained into the perivenous space, resulting in bulk flow and washout of macromolecules in the ECS
(From: Rasmussen et al., 2018).

The transport stoichiometry of GluTs is responsible for GluTs’ function as high-affinity
secondary-active transporter.
GluTs are secondary-active transporters that use the electrochemical sodium/potassium
gradients, which are stablished by the Na+/ K+-ATPase, to co-transport Glu with three sodium
ions and a proton in exchange for an internal potassium ion (Amara & Fontana, 2002; Amato et
al., 1994; L. M. Levy et al., 1998; Zerangue & Kavanaugh, 1996) [Figure 5]. This specific
stoichiometry provides a strong driving force in favor of Glu uptake against its concentration
gradient that maintains external Glu within the ~25nM range (Herman & Jahr, 2007). This is far
below the measured EC50 of GluR for Glu (~2µM) (Patneau & Mayer, 1990), keeping GluR
from being overactive or desensitized (Tzingounis & Wadiche, 2007). The transport balance
makes these GluTs electrogenic because two net positive charges move into the cell after each
transport cycle (Kanai et al., 1995). Additionally, some neuronal GluTs exhibit uncoupled Clconductance through a transporter opening/pore (Arriza et al., 1997; Machtens et al., 2015;
Wadiche et al., 1995). From mutagenesis studies, inhibition of Glu transport through these
transporters does not inhibit Cl- conductance (Tzingounis & Wadiche, 2007). Such Cl- influx
would offset depolarizing effects on an activated cell.
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Figure 5: Synaptic architecture: an action potential from the presynaptic neuron triggers the release of
glutamate (Glu) into the synaptic cleft resulting in several events. (1) activation of glutamate receptors (NMDA,
AMPR) on the post-synaptic neuron allowing for cation influx and (2) Glu uptake by neuronal and glia-expressed
Glu transporters (GluTs). Transporter uptake cycle consists of the binding of three sodium ions, a Glu molecule,
and a hydrogen (not depicted) are co transported inwards, in exchange for a potassium ion. Glu is then recycled
back into the presynaptic neuron via the Glu/glutamine cycle and repackaged into vesicles by the vesicular Glu
transporter (vGluT). Although all GluTs have the ability to allow passage of Cl- ions, it is prominently performed by
neuronal GluTs.

Following uptake, Glu must either be used for metabolic purposes or recycled back into
the presynaptic neuron via the Glu/glutamine cycle - both of which are critical for continuation
of its uptake (Danbolt, 2001). Glu is then repackaged into vesicles by the vesicular Glu
transporter (vGluT) in preparation for its next release (Hamberger et al., 1979; Thanki et al.,
1983). It’s important to note that while GluTs do not depend on ATP, the proteins involved in
stablishing the Na+/K+ gradient as well as the Glu/glutamine cycle requires ATP expenditure.

This means that GluT stoichiometry makes the transport of Glu energetically costly,
requiring one ATP for each Glu transported (Masliah et al., 1996), and so it is particularly
sensitive in declining Na+/ K+-ATPase activity as seen in brain ischemia (Choi & Rothman,
1990; Grewer et al., 2008; Ketheeswaranathan et al., 2011; Rao et al., 2001). Malfunction of
these transporter has been associate with a wide range of other diseases (Maragakis & Rothstein,
2004; Sheldon & Robinson, 2007) such as: Alzheimer disease (Busche et al., 2008; Duerson et
al., 2009; Hefendehl et al., 2016; S. Li et al., 2009; Masliah et al., 1996; Revett et al., 2013; Zott
et al., 2019), Alcoholism (Rao & Sari, 2012) , ALS (Rothstein, 2009), Austism (Waly et al.,
2012), brain ischemia (Choi & Rothman, 1990; Grewer et al., 2008; Ketheeswaranathan et al.,
2011; V. L. R. Rao et al., 2001), Depression (Lang & Borgwardt, 2013), Diabetes
(Jayanarayanan et al., 2013), Epilepsy (Crino et al., 2002; Tanaka et al., 1997), HIV-related CNS
disorder (Porcheray et al., 2006), Huntington (Estrada-Sánchez & Rebec, 2012), Manganism
(Lee et al., 2009), Multiple Sclerosis (Tameh et al., 2013), Neuropathic Pain (Maeda et al.,
2008), Obisity (Valladolid-Acebes et al., 2012), OCD (Arnold et al., 2006), Parkinson (Massie et
al., 2010; Plaitakis & Shashidharan, 2000), Schizophrenia (Karlsson, Tanaka, Heilig, et al., 2008;
Karlsson, Tanaka, Saksida, et al., 2008), Tourette (Adamczyk et al., 2011), and West Nile Virus
(Blakely et al., 2009). It is no surprise that GluTs are seen in this plethora of diseases as Glu is
the nervous system’s NT of choice. It is important to note that it is not clear whether the
malfunction of GluTs cause these disease or the disease causes malfunction of transporters.

The significance of GluT transport stoichiometry could be further appreciated upon
deeper analysis. Zerangue and Kavanaugh (1996) applied the zero-flux equation (an equation
that defines the thermodynamic equilibrium membrane potential when the influx of glutamate to

the cytosol equals the efflux of glutamate to the extracellular space) to predict that cotransport of
three sodium ions per cycle would be sufficient to maintain external Glu in the low nanomolar
range. In contrast, transport use of two sodium ions per cycle would have an external Glu
concentration more than 250-fold higher and with apparent lower affinity. This model was
supported by Xenopus studies of EAAT3 Glu uptake (Grewer et al., 2014; Zerangue &
Kavanaugh, 1996) [Figure 6] and CA1 pyramidal cells in hippocampal slices (Herman & Jahr,
2007).
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Figure 6: GluT stoichiometry: Early experiments by Zerenque and Kavanough (1996) applied a mathematical
equation, zero-flux, that considers relative in/out ion concentrations, and an estimated number on ions transported
per cycle. A GluT that uses 3Na+ per cycle with maintain external Glu concentrations in the nanomolar range for a
a cell that has a resting membrane potential of -70mV (dashed line). 2Na+ per cycle would maintain external Glu
concentration in the micromolar range for the same resting membrane potential.

Mammals have five GluTs of the Solute Carrier 1A family (SLC1A), known in humans
as excitatory amino acid transporter (SLC1A1-5/EAAT1-5) [Table1]. In addition to these cellmembrane transporters, designated neurons also express vesicular glutamate transporter

(SLC17A6-8/vGluT1-3), which are unrelated in structure to the cell-membrane GluTs (Chang et
al., 2018). The mammalian GluT SLC1A3/GLAST/EAAT1 is predominantly expressed in
cerebellar Bergman glia (Lehre & Danbolt, 1998) but has also been found in the retina (Rauen et
al., 1996) and hippocampus (Lehre & Danbolt, 1998). SLC1A2/GLT-1/EAAT2 is the
predominant glial-expressed GluT in the CNS expect where EAAT1 is expressed and it is
responsible for clearing >90% of Glu (Lehre & Danbolt, 1998). SLC1A1/EAAC1/EAAT3 is
expressed in neurons, primarily in the hippocampus but also found in cerebellum (Conti et al.,
1998; Haugeto et al., 1996; Holmseth et al., 2012; Kugler & Schmitt, 1999; Rothstein et al.,
1994). SLC1A6/EAAT4 is predominantly expressed in cerebellar Purkinje cells (Dehnes et al.,
1998). SLC1A7/EAAT 5 is exclusively expressed in the retina’s rods, cones, and bipolar cells
(Pow & Barnett, 2000; Wersinger et al., 2006). It is interesting to note that although
superficially the different mammalian GluTs have similar characteristics, some critical
differences can be observed. At first look, the major human GluTs (EAAT1-3) seem to have
similar KM steady state values (Tzingounis & Wadiche, 2007; Vandenberg & Ryan, 2013).
However, when we examine the initial Peak currents (Pre-Steady-State Affinity Kd in Table1) of
GluT activity, we can see these EAATs show different Glu affinity constants (Kd) (Bergles et al.,
2002; Mennerick et al., 1999; Otis & Jahr, 1998; Wadiche & Kavanaugh, 1998) [Figure 7]. For
example, EAAT2, the predominant glial-expressed GluT in the brain has 10X lower apparent
affinity than the intra-synaptic neuronal EAAT3 (Tzingounis & Wadiche, 2007) (Figure 7,
Table1). The higher Glu affinity of neuronal EAAT3 suggests they behave as buffers that bind
to external Glu with high affinity (Diamond & Jahr, 1997; Tong & Jahr, 1994), while lower
affinity glial EAAT2 act as Glu sinks at the synapse removing the majority of Glu (Tzingounis &
Wadiche, 2007).

Table 1: The kinetic parameters of five different human GluTs known as EAAT1 -5. Differences in apparent pre-steady-state
affinity are noted while stead-state transport is relatively similar throughout the main transporters EAAT1-3 (Vandenberg &
Ryan, 2013).

Figure 7: Currents produced by initial Glu binding (Peak current) and transient Glu transport (Steady-state
current). a and b represent the Peak and Steady-state currents for EAAT2. c, d represent the Peak currents produce
by hippocampal and cerebellar EAATs ((Tzingounis & Wadiche, 2007)

Understanding the main features of GluT physiology might guide a search for the
molecular components that furnish these attributes, correlating GluT structural features to their
function.

At the micro level of neurotransmission, a diverse class of sequence-distinct GluTs may hold the
key to successful Glu clearance
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GluTs are found across species from humans to archaea. Indeed, the crystallization of the
archaeal GluT (GltPh) is the cornerstone of our understanding of GluT structure, an achievement
followed later by the structural analysis of other archaeal (such as GluTk) and mammalian (such
as EAAT1) GluTs. These transporters form homotrimers, where each subunit (protomer)

functions independently of one another (Ruan et al., 2017). Each protomer is composed of eight
transmembrane alpha-helixes (TM1-8) and two hairpin loops (HP1-2) that partially span the
bilayer, each from either side of the membrane [Figure 8] (Boudker et al., 2007; Yernool et al.,
2004). TM1, TM2, TM4, and TM5 make up an external ‘scaffold domain’, which stabilized the
protein as a trimer and helps anchor at the membrane. TM3, TM6, TM7, TM8, HP1, and HP2
make up an internal ‘transport domain’ which contains the ligand binding sites and moves in an
elevator-like motion (Boudker et al., 2007; Reyes et al., 2009) [Figure 9 A-D].
Although the Archaeal glutamate transporter (Gltph) differs from mammalian GluTs in
preference of aspartate (Asp) over Glu and transporter does not rely on proton or potassium
gradients, their structure and function remain highly similar (Ryan et al., 2009). Thanks to the
study of Gltph crystal structure (Pavić et al., 2019; Yernool et al., 2004), the ion-substrate binding
order and the residues involved in forming ligand-binding pockets are now clearer: in the
outward facing conformation (OFC) two sodium ions bind to sodium pocket Na1 and Na3,
followed by binding of Asp/Glu, a proton, and finally a third sodium ion to pocket Na2. The
transporter then goes through a conformational change to inward facing confirmation (IFC)
where ligands are release into the cytoplasm and a potassium binds to return to the OFC. The K+
binding pockets are not completely clear, but some studies suggest overlap with Na+ binding
pockets (Guskov et al., 2016; Kortzak et al., 2019).
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was added to depict binding pocket. Although potential K+ ion binding sites exist in GltPh, transporter does not
depend K+ binding to exhibit conformation change.

Special importance is placed on the conserved NMDGT motif, found in the middle of
TM7 (Boudker et al., 2007; Yernool et al., 2004), and other conserved sequences that are critical
for stable ligand binding affinities and functional transport/exchange (Heinzelmann & Kuyucak,
2014). Moreover, Na1 is coordinated by (GltPh numbering) TM7 (G306, N310), and TM8 (N401,
D405). Na3 is coordinated by TM7 (T308, M311), and HP2 (S349, I350, T352) (Ji et al., 2016;
Pavić et al., 2019). Na2 is coordinated by TM3 (Y89, T92, S93), and TM7 (N310, D312)
(Bastug et al., 2012). Asp/Glu binding is coordinated by TM7 (T314), TM8 (N401, D394,
R397), HP1(S278, R276), and HP2 (V355) (Guskov et al., 2016; Ji et al., 2016; Pavić et al.,
2019). Despite the names, these sodium binding pockets have order of affinities from highest to
lowest Na3>Na1>Na2 (Bastug et al., 2012; Heinzelmann et al., 2011, 2013; Pavić et al., 2019).

A possible biological explanation for having sequence-distinct GluTs expression patterns might
be due to inherent differences in substrate affinity and capacity
As noted above, different mammalian GluTs show differential properties in term of their
peak-current apparent affinities. Reduced transport affinity is usually coupled with an increase
transport capacity as seen in bacterial adjustments to environmental flux (Levy et al., 2011), in
renal glucose reabsorption (Bailey, 2011), and in hepatic uptake of cationic amino acids (Closs et
al., 1993). Given the differences in their peak EC50, it is interesting to speculate if the glial
GluTs have a lower affinity but higher transport capacity and vice versa compared to neuronal
GluTs. It is unclear how GluTs with diverse properties and expression patterns contribute to
clearance of Glu in the normal CNS. In theory, a GluT mixture of high affinity/low capacity and
low affinity/high capacity along with fluid bulk flow can effectively clear a wide range of
morphological and functional scenarios of excitatory signaling [Figure 10]. However, the

physiological significance of such differences among GluTs remain unclear. It is therefore
interesting to study a system where physiological differences between GluTs can be assessed
more readily.
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Figure 10: Depiction of the effect of combination of high affinity/low capacity and low affinity/high capacity
transporters in different scenarios. Panel A shows a low affinity/high capacity transporter acting as a sink to
remove the majority of substrates when the substrate is plentiful, while the high affinity/low capacity transporter has
a small contribution to overall clearance because it transports substrates at a slow pace. Panel B shows a scenario
where much of the substrate has already been cleared, so that the high affinity/low capacity transporter would
continue to perform clearance by binding even to low concentrations of extracellular substrate, while the low
affinity/high capacity transporter is unable to provide further clearance.

The nematode is an excellent model organism to study a dynamic mechanism of Glu Clearance
Studying Glu clearance by GluTs and bulk flow is a challenge in mammals:
neurophysiological techniques require surgery that disrupts the normal dynamics of synaptic and
interstitial fluids (Sun et al., 2014), or rely on slice or cell culture preparations where the fluid
flow dynamics is not preserved. To address the gap in our understanding of GluTs and study
basic principles of Glu clearance in glia-deprived synaptic hubs we turn to the model system of
the transparent nematode C. elegans. One of the greatest advantages of C. elegans is that most
mutant worm strains are viable and able to propagate via self-fertilization (WormBook). With
powerful genetics, molecular and optogenetic tools (Chronis et al., 2007; Fang-Yen et al., 2015;
Husson et al., 2013), and with detailed descriptions of its entire nervous system and the behavior

it produces (Ardiel & Rankin, 2010; Bargmann, 1993; Bono & Maricq, 2005; Brittin et al., 2018;
Cook et al., 2019; Jarrell et al., 2012; Sasakura & Mori, 2012; White et al., 1986), C. elegans is
an excellent organism to study normal nervous system physiology.

Glutamatergic signaling and GluTs are highly conserved in C. elegans
Consisting of 300 neurons 56 glia cells, most of the C. elegans synapses are found in a
doughnut-shaped structure that bands around the pharynx, known as the nerve ring. The nerve
ring is the hub of neuronal communication is the nematode, and it makes multiple synapses
between neurites en passant (White et al., 1986). EM studies show four cephalic glia cells wrap
around the outer surface of the nerve ring in a single layer and does not provide anatomical
separation of synapses or interstitial fluids in the neuropil (Oikonomou & Shaham, 2010; Singhvi
& Shaham, 2019). Like in the mammalian nervous system, Glu is a key excitatory NT that acts
in about 1/3 of the nematode’s central synapses (Brockie, P. J. and Maricq, A. V., 2006; SerranoSaiz et al., 2013) where it mediates critical behaviors. Unlike mammals, these circuits are clearly
trackable (Brockie, P. J. and Maricq, A. V., 2006; Chalasani et al., 2007). The molecular building
blocks and mechanisms of Glutamatergic synapse function are well conserved in C. elegans,
including vGluT (EAT-4), iGluR, and mGluR. The C. elegans genome also contains six highly
conserved cell surface GluTs (glt-1,3,4,5,6,7) homologous to their mammalian counterparts in
both sequence (particularly in the ligand binding sites, see Figure 17), and function (Brockie, P. J.
and Maricq, A. V., 2006; M. Katz et al., 2019; Mano et al., 2007). Therefore, C. elegans manages

to keep a functional and high resolution Glu signaling system despite of the lack of synaptic
isolation, glial coverage, and the widespread use of the same NT in many adjacent synapses. In
our studies we ask whether these challenges are addressed in C. elegans by a compensatory,

especially robust, function of a diverse class of sequence-distinct GluTs to maintain the accuracy
of the Glu signaling and circuit resolution in the nerve ring.

Nematode GluTs: Overall conservation, preliminary suggestion of possible deviation in some
nematode GluTs
Sequence analysis of the conserved ligand-binding regions and comparison to published
mutagenesis studies suggested that some GluTs might serve as mediocre or non-functional
transporters. For example, an alanine substitution of a conserved TM3 residue, which makes part
of the Na3 binding pocket (map position 101), in Gltph (S93) and corresponding human EAAT1
(T131A) showed significant decrease in Na+ affinity and hence Glu affinities by a full order of
magnitude (Bastug et al., 2012; Heinzelmann & Kuyucak, 2014). The nematode sequence for
glt-5,6 shows a valine and alanine for the same positions, respectively (Figure 17). A glutamine
substitution for conserved asparagine (of NMDGT motif) (map position 415-419) in Gltph (N310)
and EAAT3 (N366Q) resulted in a significant 2X and 3X orders of magnitude drop in aspartate
and glutamate affinity, respectively (Heinzelmann & Kuyucak, 2014; Rosental et al., 2006). The
C. elegans glt-3 shows a threonine for the same position. A serine substitution for conserved
threonine (of NMDGT motif) (map position 419) in EAAT3 (T370S) resulted in a significant 2X
orders of magnitude drop in glutamate affinity (Borre & Kanner, 2001; Heinzelmann &
Kuyucak, 2014; Larsson et al., 2010; Teichman et al., 2012). The C. elegans glt-6,7 show an
asparagine for the same position. Of interest is the map position 381 that makes up part of the
Asp/Glu binding pocket and is require for adequate Glu clearance in human EAAT1 (S363) and
EAAT3 (S331). Previous mutagenesis studies have shown a significant increase affinity for Glu
and inversely a decrease in transport capacity. Interestingly, predominant EAAT2 and all

nematode distal transporters and glt-1 show an alanine, while neuronal EAAT-3,4,5 and
nematode neuronal glt-4 show an alanine for the same location (Borre & Kanner, 2003; CanulTec et al., 2017; Ryan et al., 2010) [Figure 17]. Although non-conserved regions are not a
primary focus on mutagenesis studies, some of these mutation in Gltph and human EAATs at
conserved regions results in GluTs malfunction. In contrast, in C. elegans these sequence
differences do not seem to affect normal physiology. It is possible that neighboring nonconserve helixes help stabilize C. elegans GluTs.

Previous experiments in our lab identified six GluTs with distinct expression patterns (distal
versus proximal) and different residues at key ion-binding sites
In previous studies of Glu clearance in C. elegans we have identified six GluTs (glt1,3,4,5,6,7) (Mano et al., 2007). Two of which, glt-1 and glt-4, are expressed relatively closed to
the main glutamatergic synapses in the nerve ring and are therefore labeled proximal: glt-1 in
head muscles, hypothermis and cephalic glia (M. Katz et al., 2019); glt-4 in some neurons with
expression that at least partially correlated with that of vesicular GluT (vGluT) eat-4 (Cao et al.,
2017), sometimes even showing colocalization at presynaptic area of the neurites (Li et al.,
2016). In contrast, three GluTs, glt-3, glt-6, and glt-7, are expressed relatively distant from the
main glutamatergic synapses, with shortest distance of about 10 microns away in the nerve ring
and are therefore labeled as distal [Figure 11]. Distal GluTs are all expressed on the body-long
H-shaped tubular canal cell which passes the nerve ring ventro-laterally. The role of the distal
GluTs is further emphasized by the observation that distal (but not proximal) GluT KOs causes
excitotoxic neurodegeneration in a sensitize background (Mano & Driscoll, 2009). Interestingly,
all three distal GluTs exhibit few but major deviation from classically conserved amino acid

sequence in ligand-binding residues, suggesting that distal GluTs might have unique functional
properties.
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Figure 11: Previous C. elegans GluT::GFP fusion experiments (Mano 2007): Distal versus proximal GluT
expression determined by proximity to the nerve ring. Proximal GluTs consists of glt-1 and glt-4 while distal GluTs
consists of glt-3, glt-6, glt-7. (Mano et al., 2007)

Two adjacent circuits are preferentially cleared by different proximal versus distal GluTs
To further study the effects of both proximal and distal GluT KOs, we focused on two
opposite but adjacent circuits located in the nerve ring: a nociceptive circuit
(ASH→AVA/AVD/AVE) that results in an avoidance response (Mellem et al., 2002; Piggott et
al., 2011; Ventimiglia & Bargmann, 2017), and an attractive circuit (ASE→AIB/AIA/AIY) that
results in a chemotaxis response (Altun, Z. F. et al. Wormatlas, 2018; Kato et al., 2014;
Kunitomo et al., 2013).
In more recent work, our lab focused on cellular physiology studies by using the Chronis
and Bargmann nematode microfluidic imaging system [Figure 12] (Chalasani et al., 2007, 2010;
Chronis, 2009; Chronis et al., 2007) paired with GCaMP3 calcium imaging [Figure 15 B] (using
zfIs42[Prig-3::GCaMP3::SL2::mCherry)(Shipley et al., 2014). The KO of distal (glt-3,6,7) (but

not proximal) GluTs indeed resulted in a strong potentiation of noxious ASH→AVA responses
[Figure 15 C]. Therefore, the distal GluTs have a privilege role in clearing
ASH→AVA/AVD/AVE synapses. Furthermore, the KO of proximal (glt-1,4) (but not distal)
GluTs resulted in cross-circuit signaling, potentially suggesting Glu spillover from adjacent
ASE→AIB circuit on AVA-GCaMP neuron upon chemotaxis stimulation [Figure 15 A]. To
confirm that the responses we follow originate in Glu release from the presynaptic neurons we
suspect requires us to be able to release Glu from only one (or a pair of-) neuron(s) and detect its
action on identified postsynaptic neurons. We are therefore interested in determining whether
knocking out vGluTs (eat-4) decreases Glu signaling in these circuits and whether we can rescue
such phenotype by cell specific rescue of eat-4.
We believe that a combination of functionally different GluTs along with bulk flow help
maintain healthy levels of extracellular Glu. We can begin to study this question by swapping
transporters to test if the expression of one transporter can substitute for the omission of another
(while expressed in the same location). To ensure the validity of this approach, we need to make
sure to avoid overexpression of transgenic constructs, since it can obscure functional differences
between GluTs. We therefore take special care to express the native and the alternative GluT at
levels that are as close as possible to the original endogenous levels of GluT expression in this
location. To achieve that goal, we use advanced transgenic technology (MosSCI) to ensure
single-copy integration of GluT - coding sequences, expressed under the control of standardized
promoters. We anticipate that this careful regulation will allow us to determine if GluTs are
interchangeable or functionally specialized.

Hypothesis
We expect different GluTs to be functionally specialized: We hypothesize that key
differences in transporter residues between the proximal and distal GluTs provide unique
clearance abilities of high affinity/low and low affinity/capacity that results in robust Glu
clearance between two adjacent circuits.

Materials and Methods
Research Strategy
Microfluidics and imaging
Microfluidics was performed by Joyce Chan, a PhD student in our lab, and will be only
described here briefly. GCaMP transients from live nematodes trapped in the chip were recorded
as previously described by Chronis & Bargmann (Chronis et al., 2007). To generate the stimulant
solutions, glycerol was dissolved in S Basal buffer to a final concentration of 1 M (Chronis et al.,
2007), while 1 mM NaCl was dissolved in salt stimulation buffer.
Our imaging system consists of a Zeiss Axiovert 200 M motorized inverted microscope,
Lumencor SOLA solid-state white light source, Ludl filter wheel controller, Q Imaging EXiTM
Blue camera, and ValveBank4 controller (AutoMate). Metamorph software (Molecular Devices)
was used for image processing and acquisition. GCaMP transients were captured with a 63x
objective lens (10 frames/s).
We used DF/F to indicate change in fluorescence intensity. F was defined as the baseline
fluorescence intensity of AVA during a period of either 3 seconds (for recording effects of salt
stimulation in AVA GCaMP) or 4 seconds (for recording AVA GCaMP signals during response
to glycerol). Before recording, worms were held for one minute in the microfluidics chamber in
the presence of repulsive blue light to eliminate avoidance mediated through the photoreceptor
protein LITE-1 as detailed in Yemini et al. 2019 manuscript (Yemini et al., 2019). Intensity
measurements were restricted to AVA cell body for GCaMP imaging. This was achieved by first
setting an inclusive intensity threshold to define the range of fluorescence to capture (i.e.,
neuronal soma or process, which has higher intensity compared to other cells and structures),
then defining a region of interest (ROI) to capture from. Reporter transients were analyzed by

comparing subsequent intensity readouts to the baseline intensity, expressed as a change in
percentage.

Figure 12: A worm microfluidic ‘chip’ used to measure G-CaMP signaling. The chip traps single worms and
delivers a chemical stimulus to their nose. Streams 1 and 4 are used to redirect the stream 2 either towards or away
from the worm’s nose. Source: Chronis, N. (Frontier) Lab Chip,2010, 10, 432-437

Mos1-mediated single copy insertion (MosSCI)
Constructs for single copy transgenic integration were built according to the protocols
from Christian Frøkjær-Jensen and the Jorgensen lab (see (Frøkjær-Jensen et al., 2014) and
www.wormbuilder.org). After the discovery that Drosophila mariner element Mos1 could be
mobilized in C. elegans (Bessereau et al., 2001), tools were rapidly developed to take advantage
of Mos1-mediated transgene insertion in C. elegans (V. J. Robert & Bessereau, 2009). Mos1mediated single copy insertion (MosSCI) was developed soon after [Figure 13]: MosSCI requires
microinjections of the following extrachromosomal array into a chromosome-specific unc-119
mutant worm that contains a Mos1 element in a specific open chromosome location. The system
includes a cocktail of plasmids carrying different elements:
•

Transposase-expressing plasmid

•

donor plasmid containing the transgene of interest and unc-119+ rescue sequence

•

fluorescent co-injection markers plasmid

•

a heat-shock inducible negative selection of the extrachromosomal array, peel-1
plasmid.

At the molecular level, the transposase mobilizes the Mos1 element producing a double stranded
DNA break. These breaks are then repaired by homologous recombination with ~1.3 kb of 5’
and 3’ homology arms found in the donor plasmid and a specialized landing site on the target
chromosome (V. Robert & Bessereau, 2007).
Initially worms are injected with a mixture of all these plasmids, creating a concatemer
that strings all these plasmids on a large extrachromosomal array. The expression of the mCherry
florescent marker allows selection of animals that contain this array. A week following
injections, the worms are heat-shocked to create integration and kill animals containing the
extrachromosomal array: The heat shock activates the expression of the transposase gene. As a
result, some of the worms will create transposase-mediated integration of only the target
transgene and the unc-119+ sequence into the landing region of the target chromosome. Animals
that successfully integrated the gene of interest will also harbor the unc-119+ sequence and show
complementation of the unc-119 mutation present in this strain. To reduce the survival of
animals where integration did not happen, the heat shock also activates the toxic gene peel-1. We
screen for successful insertion candidates in animals that lack fluorescent co-injection markers
and move like WT. We confirm insertion by either PCR or sanger sequencing.

Figure 13: Overview of MosSCI integration (WormBuilder.org) Plasmids are injected into chromosome-landing
site-specific MosSCI worms: Plasmid description are as follow: hs:peel-1 is a heat-shock indictable negative
selection marker. It is used to kill worms carrying the extrachromosomal array. mCherry is a fluorescent coinjection marker used to determine successful microinjections (can be replaced by a GFP plasmid, as needed).
Positive selection marker contains UNC-119+ rescue sequence and transgene of interested flanked by ~1.3kb of left
(L) and right (R) homology arms at the 5’ and 3’ ends, respectively. hsp:transposase: is a heat-shock inducible
transposase.

Multiple Sequence Alignment
To identify sequence differences that can potentially provide GluTs the molecular basis
for their unique Glu clearance strategies, we focused on substrate binding sites. A multiple
sequence alignment was performed using Clustal Omega, a new multiple sequence alignment
program that uses seeded guide trees and HMM profile-profile techniques to generate alignments
between three or more sequences (Madeira et al., 2019). We used organism’s protein sequences
from NCBI.

Tree Alignment
The tree alignment was made using JalView(Waterhouse et al., 2009) using the Clustal
Omega file from the multiple sequence alignment (Madeira et al., 2019).

Construction of plasmids for MosSCI single copy transgenesis
We reasoned that we can explore potential transporter differences by swapping
transporters and expressing them at similar levels, and test if they are interchangeable, or
functionally specialized. For example, we can express distal GluTs cDNA are under a proximal
GluT promoter in a proximal GluT KO and vice versa. We used cDNA to diminish the level of
gene regulation naturally found in the introns. We also want to monitor the level of expression of
our transgene using a fluorescent reporter. To that end we used a splice leader sequence (SL2)
fused mCherry downstream the cDNA. The SL2 will make sure our transgene and mCherry are
translated separately, so that protein fusions don’t interfere in transport activity.
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Figure 14: Overview of all experimental design for promoter swap and integration experiment: All constructs are
built on the backbone of a plasmid that can be integrated resulting in stable and endogenous transgene expression.
Panel A shows the over plasmid construct design. The promoter and gene by the same name are the controls, while
promoter and gene with different names are the experimental. Panel B shows the overall steps taken after
integration occurs. The integrated strains will be crossed in corresponding GluT KO (i.e. Pglt-1::glt1 (or 3)cDNA is
crossed with glt-KO). The results are a total of four strains.

Worm Strains and Maintenance
Previously established strains: All Caenorhabditis elegans strains were cultured at 20°C
on MYOB plates (Church et al., 1995) with Escherichia coli strain OP50 as food source
(WormBook). Our wild type strain is Bristol N2. Other strains used for this study are: For
GCaMP imaging in AVA: QW625 (lin-15; zfIs42[Prig-3::GCaMP3::SL2::mCherry; lin-15(+)]);

IMN18: glt-1(ok206) X; zfIs42 ; IMN19: glt-3(bz34), glt-6(tm1316), glt-7(tm1641) IV; zfIs42 ;
IMN20: glt-4(bz69) X, zfIs42 ; Details of the glt mutant strains were previously described (Mano
et al., 2007). The strains carrying glt mutations and AVA neurons expressing GCaMP (IMN18,
IMN19, IMN20, IMN50 and IMN51) were generated by crosses between the corresponding glt
mutants and the QW625 strain. QW625 (Shipley et al., 2014) was a gift from the Alkema lab (U.
Mass. Med. Sch.) and was obtained via the Biron lab (U. Chicago) (Iwanir et al., 2013).

Analysis of GluT function under cell-specific release of Glu: To confirm that the signals
seen in our AVA GCaMP imaging of glt strains arise in response to glutamatergic signals, I
crossed our GCaMP-expressing glt mutants with eat-4 loss-of-function mutant MT6308 (eat-4
(ky5) III). I then restored Glu release to specific presynaptic neurons by expressing EAT-4 under
cell-specific promoters. For ASH-specific eat-4 rescue in an eat-4 mutant background, I crossed
glt mutant strains containing eat-4 loss-of-function mutation (ky55) with a strain containing a
transgene that expresses EAT-4 under the promoter of the ASH-specific gene sra-6: TQ2905
(xuEx929: [Psra-6::eat-4(cDNA)::sl2::yfp1+Pnpr-9::dsred+Punc-122::rfp]; eat-4(ky55)) strain
(Piggott et al., 2011), obtained from the Xu lab (U. Mich). For ASEL-specific eat-4 rescue in an
eat-4 mutant background, glt strains containing eat-4 loss-of-function mutation were injected
with expression plasmids containing wild-type eat-4 cDNA [Pgcy-7::eat-4(cDNA)].

Single-copy transgenic expression of GluTs: To test if different GluTs are functionally
interchangeable or not, we use the Jorgensen lab’s MosSCI technology (Frøkjær-Jensen et al.,
2008). For transgene construction see the following sections. In terms of nematode strain, our
MosSCI integration strain type is EG0979 with landing sites on chromosome II: 1.73.

Molecular Biology: Construction of GluT expression-swapping transgenes
For all plasmid constructs with cDNA, total RNA was extracted from C. elegans Bristol
strain N2 in TRIzol (Invitrogen) using RNeasy Mini Kit (Qiagen). RNA was used as template to
create an mRNA-cDNA prep using Invitrogen SuperScript® III and Oligo(dT)20 following
manufacture’s protocol. All PCR fragments were amplified using NEB Q5 polymerase and were
either purified via spin column purification or gel purified using NEB Monarch® DNA Gel
Extraction Kit. All plasmids were assembled via Gibson assembly (Gibson et al., 2009) using
NEB HiFi Assembly following manufacture’s protocol.

Construction of Pglt-3::GLT-1cDNA::SL2::mCherry
The glt-3 promoter was amplified from 263bp upstream the glt-3 ATG start site (Mano et
al., 2007; Mano & Driscoll, 2009; Shaye & Greenwald, 2015) from genomic DNA using primers
5’- cttgcacttataGCTTTCGAATCGTTGTTTAATTTTACTGG containing 12bp overlapping the
ttTi5605 right recombination arm of pCFJ150 vector plasmid at the 5’ end and 5’gttctatgttatgttagtatcattcgaaacatacCTTGTCTGTGTTGT with 34bp at the 5’ end to include a
synthetic intron before the cDNA sequence downstream. pCFJ150 - pDESTttTi5605[R4-R3] was
a gift from Erik Jorgensen (Addgene plasmid # 19329) (Frøkjær-Jensen et al., 2008). Adding a
synthetic intron between promoter and gene has been shown to improve gene expression (Nance
& Frøkjær-Jensen, 2019). The C. elegans GLT-1 protein has two isoforms, GLT-1a and GLT-1b,
with GLT-1b being 11 amino acids shorter at the N-terminus (Kawano et al., 1996; KAWANO et
al., 1997). Later studies showed GLT-1b to be four folds more active in Glu uptake than GLT1a
(KAWANO et al., 1997). We therefore focused on the active, shorter, b- form of GLT-1. We

amplified glt-1b cDNA from cDNA prep using primers 5’gaatgatactaacataacatagaacattttcagATGGTATCCTGG with 33bp at the 5’ end to include a
synthetic intro upstream and 5’- tgagacagcTCAATGAGTGTGCTTCTCGTCATCC with 9bp
overlapping the SL2 sequence. The SL2::mCherry::UNC-54 3’UTR was amplified from XW09
plasmid using primers 5’- ctcattgaGCTGTCTCATCCTACTTTCACCTAGT with 8bp
overlapping glt-1cDNA and 5’ttagagaatgtcGAAACAGTTATGTTTGGTATATTGGGAATGTATTCTG with 11bp
overlapping UNC-119 promoter in the pCFJ150 plasmid vector. XW09 was a gift from Kang
Shen (Addgene plasmid # 65833) (Wei et al., 2012). The pCFJ150 vector was amplified using
5’- cataactgtttcGACATTCTCTAATGAAAAAATCTTTCAGTTGAAATTGAAAATGAG with
13bp overlapping the UNC-54 3’UTR and 5’tcgaaagcTATAAGTGCAAGTAAGATCAGTGTTTGTTTCG with 8bp overlapping the glt-3
promoter. Following Gibson assembly, plasmid was transformed into Invitrogen One Shot™
competent cells (Cat# C404010)

Construction of Pglt-3::GLT-3cDNA::SL2::mCherry
The GLT-3cDNA was amplified from cDNA prep using primers 5’ATGGGCATGAAGAAGGATCT and 5’- TTAGACAATATGGGTGTCAGACTTG and
inserted in TOPO vector by Invitrogen Zero Blunt™ TOPO™ vector (Cat# 450245). We reamplified the GLT-3cDNA from the GLT-3cDNA TOPO plasmid to add overlapping sequences
using primers 5’- cgaatgatactaacataacatagaacattttcagATGGGCATGAAGAAGGATCTTCTT
with 34bp at the 5’ end to include a synthetic intron and 5’gatgagacagcTTAGACAATATGGGTGTCAGACTTGTTCAA with 11bp overlapping with SL2

sequence. We used the previously made Pglt-3::GLT-1cDNA::SL2::mCherry as a template to
amplify Pglt-3::--::SL2::mCherry as a whole using primers 5’atattgtctaaGCTGTCTCATCCTACTTTCACCTAGT and 5’GTTCTATGTTATGTTAGTATCATTCGAAACATACCTTGTCTGTGTTGT. Following
Gibson assembly, plasmid was transformed into Invitrogen One Shot™ competent cells (Cat#
C404010)

Construction of Pglt-1::GLT-3cDNA::SL2::mCherry
The glt-1 promoter was amplified from 4kb upstream of the ATG start codon (M. Katz et
al., 2019; Mano et al., 2007) from genomic DNA using primers 5’GAAAATGCTCGAGCAGTTTTC and 5’- CGTTTTGTGACTGTAGGTTTTGAAGG. Gel
purified fragments were inserted into Invitrogen Zero Blunt™ TOPO™ vector (Cat# 450245).
We re-amplified the glt-1 promoter from the glt-1 TOPO plasmid to include overlapping
sequences using 5’- cttgcacttaGAAAATGCTCGAGCAGTTTTCCAATTTTG with 10bp
overlapping the ttTi5605 right recombination sequence and 5’gttctatgttatgttagtatcattcgaaacataCGTTTTGTGACTGTAGGTTTTGAAGG with 34bp to add a
synthetic intron. We used the previously made Pglt-3::GLT-3cDNA::SL2::mCherry to swap out
the Pglt-3 for Pglt-1 using primers 5’gagcattttcTAAGTGCAAGTAAGATCAGTGTTTGTTTCG and 5’CGAATGATACTAACATAACATAGAACATTTTCAGATGGGCATGAAGAAGGATCTTCT
T. Following Gibson assembly, plasmid was transformed into Invitrogen One Shot™ competent
cells (Cat# C404010)

Construction of Pglt-1::GLT-1cDNA::SL2::mCherry
Although not yet completed, we will use the Pglt-1::GLT-3cDNA::SL2::mCherry
plasmid and swap out the GLT-3cDNA for GLT1cDNA with Gibson assembly. We will amplify
GLT-1cDNA using the Pglt-3::GLT-1cDNA::SL2::mCherry plasmid as previously described
with primers 5’- gaatgatactaacataacatagaacattttcagATGGTATCCTGG 5’CTCATTGAgctgtctcatcctactttcacctagt. For Pglt-1:---::SL2::mCherry we will use primers 5’cttgcacttaGAAAATGCTCGAGCAGTTTTCCAATTTTG and 5’gttctatgttatgttagtatcattcgaaacataCGTTTTGTGACTGTAGGTTTTGAAGG.
Construction of Pgcy-7::EAT-4cDNA::UNC-54 3’UTR

To restore Glu release specifically to the ASEL neuron we expressed EAT-4 cDNA
under gcy-7 promoter. The gcy-7 promoter was amplified from1.3 kb upstream regulatory region
of the gcy-7 gene from genomic DNA(Chang et al., 2003; Yu et al., 1997), using primers 5’AATGAAATTCGCCCACGGTTTTTTTTACCT and 5’CATGACGACATGATTATTTTCTTATGCTAAACTGGCAGAC. The cDNA prep was used as
template to synthesize eat-4 cDNA using primers 5’AGAAAATAATCATGTCGTCATGGAACGAGGC and 5’CGTTAGTTAGCTACCACTGCTGATAATGCGGATTT. pPD95_75 vector was linearized and
GFP sequence was removed using primers 5CAGTGGTAGCTAACTAACGAGTAATATTTAAATTTTCAGCATCTCGC and 5’GTGGGCGAATTTCATTTCCAAGTTGTTAGCGTATCCA. pPD95_75 was a gift from
Andrew Fire (Addgene plasmid # 1494). Following Gibson assembly, plasmid was transformed
into Invitrogen DH5a Competent Cells (Cat # 18265017).

MosSCI Single Transgene Copy Integration and Microinjection
MosSCI technologies followed protocols by C. Frøkjær-Jensen and the Jorgensen lab
(Frøkjær-Jensen et al., 2008). All microinjection mixtures contained 30 ng of our MosSCI
transgene plasmid, 50 ng of Mos1 transposase –encoding plasmid (pCFJ601), 10 ng of
ubiquitous green-fluorescent histone co-injection marker (pCFJ420), 2.5 ng of green-fluorescent
pharynx muscle co-injection marker (pCF421), and 10 ng of a heat-shock inducible negative
selection transgene (peel-1) (pMA122). All plasmids were purified using Invitrogen PureLink
Quick Plasmid Miniprep (Cat# K210010). After microinjections, we followed the MosSCI
Integration protocol as previously described (Frøkjær-Jensen et al., 2008).

Result
Proximal and not distal GluTs KO have a privilege role over Glu clearance of the ASE→AIB
avoidance response: Analysis of single neuron Glu release (Collaboration with Graduate student
Joyce Chan)
Joyce Chan, a PhD student in the lab, has previously determined that different GluTs
have a privileged role in responses of the AVA neuron when stimulated by different circuits.
However, we were missing a precise determination of the cellular origin of the Glu that ended up
stimulating AVA under different conditions. I now collaborated with Joyce to investigate the
identity of specific presynaptic neurons as origin of Glu release in these experiments. We did that
by removing all Glu release in the animal (using a KO of the vGluT gene eat-4), and then
restoring it to specific presynaptic neurons (using transgene expression under cell-specific
promoter). To investigate the functional roles of the different classes of GluTs in Glu spillover
between the ASE→AIB and ASH→AVA circuits we generated strains that will help determine
Glu clearance preference by either the proximal or distal GluTs. We crossed the proximal glt-1,
and glt-4 KO and triple-glt-3,6,7 KO strain with AVA calcium-sensing strain (GCaMP).
We followed excessive synaptic activity within the ASH→AVA circuit using ASH
stimulation by glycerol. We found that maximum fluorescent intensity was generated in AVAGCaMP by 1M glycerol stimulation in glt-3,6,7 KO strains and not in glt-1 and glt-4 KO strains
[Figure 14 C]. Spillover responses from the ASE→AIB to the ASH→AVA circuit were
measured by monitoring in vivo GCaMP fluorescence intensity, changes in AVA following 1mM
NaCl stimulation (a stimulation that is sensed specifically by the ASEL sensory neuron).
Comparing the responses in different GluT KO backgrounds, we saw that maximum fluorescent

intensity was generated in AVA-GCaMP by 1mM NaCl stimulation in glt-1 and glt-4 KO
background and not proximal glt-3,6,7 KO background [Figure 16 A].
To confirm that these responses come indeed from excessive Glu release (and not other
means of depolarization, such as other chemical or electrical synapses), we crossed our GluT KO
strains with vGluT KO (eat-4). EAT-4 packages Glu into pre-synaptic vesicles in preparation of
Glu fusion and release onto the synapse. We see that eat-4 KO results in an overall decrease in
AVA-GCaMP fluorescent responses across all experiments [Figure 15 D and Figure 16 B].
To confirm that AVA’s responses to 1M Glycerol stem from Glu release specifically
from the sensory neuron ASH we crossed the GluT and eat-4 KO with a strain that expressed
eat-4 only is ASH, to create an ASH-specific vGluT rescue. These results show that Glu release
from ASH is necessary and sufficient to produce the exaggerated responses in AVA upon
elimination of distal GluTs [Figure 15E].
We similarly wanted to confirm that our recording of ASE stimulation that result in AVA
responses are also mediated by direct spillover from ASE to AVA (and not mediated by
intermediary synapses of any kind). To confirm a potential Glu spillover from the ASE→AIB
circuit onto the ASH→AVA circuits we generated a plasmid construct that rescues the EAT-4 in
ASE neuron only. I used 1.3kb of the guanylyl cyclase gcy-7 gene promoter (Chang et al., 2003;
Yu et al., 1997) and fused it to C. elegans eat-4cDNA. We microinjected the plasmid construct
into the eat-4 ko strains and performed identical AVA-GCaMP imaging.
For the 1mM NaCl stimulations in animals that have normal Glu packaging in all
neurons, our results showed strong responses only in proximal glt-1 and glt-4 KO [Figure 16 A].
These responses disappear when eat-4 is eliminated throughout the animal [Figure 16 B].
However, restoration of EAT-4 expression only in ASEL cased restoration of the normal

responses to this low salt concentration [Figure 16 C]. These results show that Glu packaging
and release from ASEL is necessary and sufficient to form the unusual responses in AVA to low
salt stimulation in the absence of proximal GluTs, proving that these responses represent bona
fide spillover of Glu between circuits.

Figure 15 : The increased sensitivity of AVA responses to 1M Glycerol in distal GluT KO is mediated by the release of Glu
from ASH. A) depiction of external stimulation and corresponding circuit. B) a cartoon showing the organization of the Ca2+ sensitive green fluorescent protein (GCaMP) in the absence and presence of calcium. C, D, E) diagrams on the left depict
preferential clearance by crossed out transporter and a possible scenario in animals with endogenous expression of EAT-4
(panel C), in animals that are eat-4 KO in (panel D), and in animals that have ASH-specific eat-4 rescue (panel E). In each of
these three panels, the central section shows averaged traces of recordings of AVA GCaMP responses to 1M glycerol stimulation
(n=5-8). The bar graphs on the right are quantification of either the average steady state GCaMP responses (panel C green box)
or overall GCaMP responses throughout each trace (panel D and E). Bar graphs are normalized to the value of control (WT
GluTs). One-way ANOVA was performed with Post hoc Bonferroni test. Statistical significance is denoted with asterisks (***
P<0.001)
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Figure 16: The increased sensitivity of AVA responses to 1mM NaCl in proximal GluT KO is mediated by the
release of Glu from ASE. Organization of each panel is similar to that of panels in Figure 15 C-F. A Effect of GluT
KO on AVA’s responses to 1mM NaCl in the presence of endogenously expressed EAT-4 ; B, AVA’s responses to
1mM NaCl when EAT-4 is eliminated ; C, AVA’s responses to 1mM NaCl when EAT-4 is specifically restored in
ASEL. In each panel, the central section represents average traces of AVA GCaMP responses to 1mM NaCl
stimulation (n=3-16) and the right section is a bar graph quantification of the average of the whole trace. Bar
graphs are normalized to the value of control (WT GluTs). One-way ANOVA was performed with Post hoc
Bonferroni test. Statistical significance denoted with asterisks (*** P<0.001)

Multiple sequence alignments suggest an evolutionary relationship between GluTs from different
organisms
To determine a possible evolutionary relationship between GluTs from different species I
constructed a multiple sequence alignment (MSA) [Figure 18] and an evolutionary tree [Figure
19]. The MSA showed highly (>40%) conserved sequences in the transport domain [Figure 18]
(Yernool et al., 2004), and less (<40%) in the scaffold domain (Sup Figure1), in correlation with
other GluTs alignments studies (Kanai et al., 2013; Yernool et al., 2004). This high degree of
conservation is observed throughout the evolutionary tree, from archaic bacteria (Gltph) to
cnidarian (Hydra, Sea Anemone), Arthropods (Drosophila, moth), Amphibians (salamander), all
the way to mammals (mouse, rat, rabbit, and humans). Many nematode GluTs (the proximal
GluTs in C. elegans and their homologs in C. briggsae and other nematodes) also have the same
classic signature. However, the distal GluTs in C. elegans and their homologs in other nematodes
show critical features not seen in any other organism. Remarkably, the cross-species conserved
NMDGT residues found in the middle of TM7 is different for the three distal GluTs (glt-3, glt-6,
and glt-7). While glt-3 shows a TMDGT motif, glt-6 and glt-7 show a NMDGN motif. These
were shown to form the pockets for Na1,3 and Glu, respectively (Pavić et al., 2019). Position
(map number on top) 414 , two residues before the NMDGT motif, is seen to have a Met in C.
elegans glt-5 as supposed to a highly conserved Thr which forms part of the Na2 binding pocket.
In TM3 at position 101 on the map is seen as a conserved Thr except in C. elegans distal glt-6,7
where an Ala and Val is placed instead. This site forms the final Na+ ion binding pocket Na2. In
HP1 position 381 (marked by black arrow) is showing a conserved Ala in EAAT2 and distal glt3,6,7 and proximal glt-1. At the same position, neuronal EAAT 3,4,5, glia EAAT1 and neuronal
glt-4 shows a Ser. This site forms part of the Asp/Glu binding pocket. Furthermore, the

evolutionary tree closely grouped distal GluTs (glt-3,6,7) together, while grouping proximal glt1(but not glt-4) with glial EAAT2 (predominant GluT in cerebrum), and the other proximal glt-4
with human neuronal cerebellar EAAT4 and retinal EAAT5. Since these modifications are
expected to be very consequential to GluT function, we propose that nematode biology involves
an unusual physiology of canal / distal GluTs. We are therefore interested to examine if the
physiology of proximal and distal GluT is similar (so that they are largely interchangeable) or
distinct (so that they are not interchangeable, even if expressed in the same location to the same
extent).
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Figure 18: Evolutionary tree of GluT sequences from a range of organisms. Phylogenetic tree groups closely
related GluTs sequences. Blue highlights nematode proximal-neuronal and other organisms neuronal GluTs, yellow
highlights nematode proximal and other organism glial GluTs, purple highlights nematode distal GluTs.

Single copy integration
Our work shows C. elegans proximal and distal GluTs have a privilege role in Glu
clearance of ASE→AIB and ASH→AVA circuits, respectively. We therefore ask, could the
sequence differences between proximal (glt-1 and glt-4) and distal (glt-3, glt-6, glt-7) GluTs
have a functional consequence in glutamate clearance. We believe that a combination of
functionally/qualitatively different GluTs allows the nematode to maintain healthy levels of
extracellular Glu under a range of circumstances. We can begin to study this question by
swapping transporters to test if the expression of one transporter can substitute for the omission
of another (while expressed in the same location). To ensure the validity of this approach, we
need to make sure to control for quantitative differences and avoid overexpression of transgenic

constructs, since it can obscure functional differences between GluTs. We therefore take special
care to express the native and the alternative GluT at levels that are as close as possible to the
original endogenous levels of GluT expression in this location. To achieve that goal, we use
advanced transgenic technology (MosSCI) to ensure single-copy integration of GluT - coding
sequences, expressed under the control of standardized promoters. We anticipate that this careful
regulation will allow us to measure qualitative differences and determine if GluTs are
interchangeable or functionally specialized.
This is a work in progress [Table2], so the following are only preliminary results of
transport expression using Mos1 Single Copy insertion (MosSCI) (Frøkjær-Jensen et al., 2008). I
have generated (and am in process of completing) stains that will express individual transporters
at endogenous levels which will allow us to test their Glu clearance properties in AVA-GCaMP
strains. My first set of experiments relates to a situation where glt-3 is eliminated, and I ask if the
physiological phenotype of glt-3 ko can be rescued completely only by expression of native
levels of GLT-3 in the canal cell, or can it be equally rescued by expressing the same levels of
GLT-1. Therefore, our first two strains generated were proximal GLT-1cDNA (experimental)
and separately GLT-3cDNA (control) expression under distal glt-3 promoter. As previously
determined, proximal GluTs are normally expressed in head neurons, hypothermis and possibly
glia, while distal GluTs are normally expressed in the H-shape canal cell (Mano et al., 2007).
Our new transgenes are were indeed expressed in the canal cell from embryo [Figure 19 A] to
adult stage [Figure 19 B-C]. In the first stage of transgene expression, the concatemer of
plasmids are expressed as an extrachromosomal array that usually involves extensive
overexpression of all transgenes. At this pre-integration stage, the over expression of our
transgenes resulted in canal cell malformation [Figure 19 B]. In contrast, integration and

selection results in loss of the over-expressing extrachromosomal concatemer. Indeed, singlecopy integration resulted in fully formed normal canal cell [Figure 19 C, D]. We are currently in
the process of crossing our MosSCI strains into AVA-GCaMP; glt-3 strains to test differences in
GluTs clearance ability. I have also created the MosSCI constructs for the complementary
experiments, where glt-1 promoter drives the expression of either glt-1 cDNA or glt-3 cDNA.
These constructs will allow us to test if the phenotypes of glt-1 ko can be rescued only by GLT-1
expression in its native location or can also be rescued by expressing GLT-3 in cells that
normally express GLT-1. Together, these experiments will demonstrate if proximal and distal
GluTs are functionally interchangeable or distinct.
Construct
Name

Plasmid
Progress

Microinjection
Progress

Insertion
Progress

Pglt-1::glt-1

Gibson worked, but the bacteria
is cutting the 4kb promoter into
1000-500bp long

Pglt-1::glt-3

Waiting to complete
construction of Pglt-1::glt-1 to
then swap glt-1 for glt-3

Pglt-3::glt-1

Complete

Complete

Inserted - Not yet sequence

Pglt-3::glt-3

Complete

Complete

Just picked several possible
MosSCi inserts on 3/16/20

Table 2: Construct building and injection progress report.
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Figure 19: Expression of Pglt-3::glt-1cDNA in the C. elegans canal cell. A) Extrachromosomal expression in eggs
(40X mag, in oil). B) Extrachromosomal expression in adult hermaphrodite (40X mag, in oil). C) Single copy
MosSCI expression in L4-adult hermaphrodite (40X mag, in oil) D) Single copy insertion expression throughout
entire canal cell in L1 hermaphrodite (20X mag). To obtain bright images for the MosSCI strains in panels C and D,
the light intensity was increased. However, overall, the expression level of the florescent marker after integration is
much lower (seem dimmer) than before integration.

Ongoing Experiments
Aim1: Swap expression of full-length transporters
Extra chromosomal transgene expression is a quick and common technique used across
C. elegans labs to expressed a desired transgene, however expression pattern is mosaic, which
means the progeny expresses transgenes at different levels, because different amounts of
plasmids happen to propagate by chance, as illustrated by the cartoon in Figure 20 (Stinchcomb
et al., 1985). Although it is possible to integrate an extrachromosomal array with stable
expression, the results are usually an over expression, which will mask the potential qualitative
differences in transporter physiology (Mariol et al., 2013). Mos1 mediated single copy insertion
(MosSCI) will allow for single copy transgene expression from the native promoter (FrøkjærJensen et al., 2008, 2014) [Figure 13]. This tool uses an active Drosophila transposase, a
plasmid-vector carrying a transposable element including a site to insert our transgene, and a
transgenic worm with chromosome-specific landing sites that correspond to the vector plasmid
(Frøkjær-Jensen et al., 2014). Fortunately, this tool will resolve several issues including little to
no gene silencing due to location of integration resulting in expression at fixed, and nearly native
physiological levels (Frøkjær-Jensen et al., 2008, 2014; Nance & Frøkjær-Jensen, 2019).
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Figure 20: Extrachromosomal versus Single Copy Insertion transgene expression: Progeny of extrachromosomal
array is mosaic – transgene expression between single-animal tissue and across different animals varies. Single
copy insertion transgene expression is stable across tissue and animal.

In the end, a total of four plasmids will be constructed and designed for integration. Two of these
plasmids are already completed, and the other two are halfway to completion. Two will contain
the promoter of a proximal GluT, glt-1 and two will contain the promoter of a distal GluT, glt-3.
Each promoter will follow with either GLT-1 or GLT-3cDNA. This will allow us to use the same
given promoter to drive the expression of either a proximal or distal-type transporter, so we can
directly compare their activities. We will perform this analysis in animals where the native GluT
in question has been knocked out. We therefore ask: what does it take to rescue the effect of a
GluT KO? Will any GluT expressed in this location (in native levels) suffice to restore normal
activity, or does it have to be rescue by the same specific GluT type? We used cDNA of the
GluTs in order to reduce potential effects of regulatory elements downstream the promoter,
which might be present in the introns and 3’UTR (Danbolt, 2001; Grewer et al., 2014; Mano et
al., 2007; Olivares-Bañuelos et al., 2019). The cDNA is followed by a trans-splicing leader
sequence 2, or SL2, fused to mCherry downstream. This will act as a transcriptional reporter for
verification, without linking the fluorescent reporter to the functional protein (to avoid potential
effect of the fusion on transporter activity) (Nance & Frøkjær-Jensen, 2019).
Future Experiments
Aim 2: Domain swapping and site-directed mutagenesis
After analyzing glutamate clearance using GCaMP imaging data from transgenic MosSCI
worms, we should be able to determine whether robust Glu clearance is due to differences in
GluT sequences or only involves their location /expression pattern (proximal versus distal). Of
particular interest is the transport domain and especially the conserved NMDGT motif because
C. elegans distal GluTs glt-3, glt-6 and glt-7 show alternative sequences of TMDGT and
NMDGN, respectively. Other sequence of interests includes sodium ion binding site, position
101 and 414 (MSA map numbering), because these sites are part of the pocket for the third and

final sodium ion. Position 101 is different in glt-5 and position 414 (TM3) is different in distal
glt-6,7. These sites might be different so that only two versus three sodium ions bind. As
previously discussed, a transporter that uses two versus three sodium ions might be more
beneficial when there is an abundance of external Glu. These sites can result in transporters with
increases or decreases affinity for Glu transport resulting in decreasing or increasing capacity,
respectively.
Single site directed mutagenesis can be very precise and informative. However, it is
possible that mutations converting a single residue found in GluT-X to that of GluT-Y will be
hard to study, because this residue is only functional in the overall structure of the transport
domain where it is naturally occurring. In other words, the naturally occurring residue in a given
site “α” might normally cooperate with another residue elsewhere in the transport domain, in site
“β”. Therefore residue “A” is functional in site “α” in GluT-X only if another residue “B” is
found in site “β”. In this scenario we can convert GluT-X to be GluT-Y –like and form a
functional GluT only if both sites “α” and “β” are modified at the same time. Indeed, a number
of single mutations studied previously in mammalian GluTs (without combining them with the
potentially paired modification) rendered the transporter non-functional (Seal et al., 2000). To
overcome this difficulty and allow a more gradual zooming in on critical determinant, I will start
my sequence swapping experiments by swapping the whole transport domain between the two
types of GluTs. I will then gradually narrow the swapped domain to ensure minimal swapping
that still keeps the transporter functional.
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Figure14: Overview of all experimental design for promoter swap and integration experiment: All constructs are
built on the backbone of a plasmid that can be integrated resulting in stable and endogenous transgene expression.
Panel A shows the overall plasmid construct design. The promoter and gene by the same name are the controls,
while promoter and gene with different names are the experimental. Panel B shows the overall steps taken after
integration occurs. The integrated strains will be crossed in corresponding GluT KO (i.e. Pglt-1::glt1 (or 3)cDNA is
crossed with glt-KO). The results are a total of four strains.
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Figure 21: Depiction of our future domain swap experiments.

Following the analysis of whole domain swapping I will then hone in on specific
residues. These are candidate sites for mutagenesis studies. For instance, if we see differences
between GLT-3 and GLT-1 in Glu clearance of the ASE circuit by recording from AVA-GCaMP,
then we can swap GLT-1’s NMDGT sequence for TMDGT and retest their role in Glu clearance.

Conclusion
In summary, we showed that C. elegans distal GluTs (glt-3,6,7) appeared to have
preferential clearance of the noxious ASH→AVA circuit because of Glu secreted by ASH
(which is insufficiently cleared when glt-3;6;7 are eliminated). Similarly, proximal GluTs (glt1,4) appeared to have a preferential clearance of the attractive ASE→AIB circuit so that in the
absence of these transporters Glu that is released from ASE spills over to AVA synapses.
The AVA-GCaMP imaging technology has some limitations in that the fluorescent GFP
signal could become bleached throughout the duration of the stimulus and can misrepresent the
changes seen in fluorescence, as seen by the downward change in fluorescence trend in all
controls and in some GluT KO. It is also important to note that Ca2+ signal do not always
represent changes in Vm (Williams et al., 2018). We must carefully analyze the change in
fluorescence signal as well as its overall trend by comparing to the control. It is also possible that
with the excess Glu, activated GluRs could have become desensitized, which limited the amount
of cations entering the cell, which could explain the downward change in fluorescent trend.
Multiple sequence alignment revealed nematode distal GluTs showed multiple
differences for residues that ion and Asp/Glu binding pockets. These residues were different
from nematode’s proximal and other species GluTs including human EAATs. We believed these
distal sequence differences could change the affinity for these substrates resulting in a difference
in transport capacity. Our extrachromosomal array expression of the GluT swapping constructs
resulted in malformation of the canal cell which further supported our decision to integrate our
constructs. In contrast, our single copy insertion expression strain showed similar levels of
mCherry expression and no morphological abnormalities, suggesting that we have overcome
quantitative issues and can now concentrate on qualitative differences in function between

proximal and distal transporters. Future swapping experiments will allow us to determine the
molecular basis of potential physiological differences between GluTs. These studies can
potentially transform our understanding of Glu clearance in normal and in pathological
neurophysiology.
Our observation on potential spillover and lack of anatomical isolation suggest that it is
not enough to understand the connectivity of the nervous system, we must also understand how it
is able to maintain functional precision, in order to grasp a wider picture and appreciate when
maintenance goes awry in disease. Even the most advance technology today provides limited
insights into the human brain. It is why model organisms like the nematode are powerful tools
that allow us to explore the evolutionarily preserved molecular players of high-resolution
connection and maintenance in the intact animal. These studies can potentially transform our
understanding of Glu clearance in normal and in disease neuronal physiology.
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Supplemental Fig 1: Complete protein sequence alignment. This is used to see that while the scaffold domain is
diverse with relatively less sequence consensus, compared to the transport domain (TM3, 6, 7, 8, HP1, 2).

Supplemental Fig 2: Predicted C. elegans Proximal GLT-1 structure (The Phyre2 web portal for protein modeling, prediction
and analysis) (Kelley et al., 2015).

Supplemental Fig 3: Predicted C. elegans distalGLT-3 structure (The Phyre2 web portal for protein modeling, prediction and
analysis) (Kelley et al., 2015)
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